QEL-001

· Quell Therapeutics Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QEL-001, covering 2026-02-24 to 2026-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients [Phase 1, Phase 2]